Allergan says 'outlier' drugmakers scaring off venture capital money

(Reuters) - The chief executive officer of Allergan Plc said his company will limit annual price increases on its prescription drugs, and that "outlier" drugmakers that have imposed huge price increases on their products are scaring off venture capital investors.

Allergan says 'outlier' drugmakers scaring off venture capital money
Read More


Bagikan Berita Ini